1 November 2018

On 29 October it was World Stroke Day. On this day European researchers presented an action plan to improve stroke care in Europe. Edo Richard, Karin Klijn and Frank-Erik de Leeuw from Radboudumc contributed to this action plan.

Mouth, speech, arm. With this campaign the Heart Foundation has been trying to  create more awareness for the signals and consequences of stroke. Acting quickly can make the difference between life and death. On October 29, World stroke day, researchers present an action plan to improve stroke care in Europe.

Overarching targets 2018-2030

For each domain of the 2018 to 2030 European Stroke Action Plan, specific targets are being set. Beyond these targets, four over-arching targets for 2030 have been identified:
- To reduce the absolute number of strokes in Europe by 10%
- To treat 90 % or more of all patients with stroke in Europe in a dedicated stroke unit as the first level of care.
- To have national plans for stroke encompassing the entire chain of care from primary prevention to life after stroke.
- To fully implement national strategies for multisector public health interventions to promote and facilitate a healthy lifestyle, and reduce environmental (including air pollution), socioeconomic and educational factors that increase the risk of stroke.

The European Stroke Stroke Action Plan can be found here.

 

Related news items


Grants for science communication at Radboudumc

22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more

UMD Catalist grant for Mohammad Alsady and Federica Conte

24 June 2020 They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency. read more

Bas Bloem elected as new member of the KNAW

30 April 2020 Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. We congratulate Bas with this election. read more

Towards molecular therapies for Myotonic Dystrophy

1 October 2019 ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent. read more

Useful new test for Parkinson's disease

28 March 2019 Diagnosing Parkinson's is not easy. In particular in the early stages, it can be difficult to distinguish Parkinson's from a group of other disorders that at first sight look identical. read more

Specific sugar is important for muscle function Treat a genetic condition with a pinch of sugar?

2 January 2019 Dirk Lefeber and colleagues have discovered that the sugar sialic acid is important for good muscle and heart function. In a family with muscle problems, they discovered a mistake in a gene that prevents the breakdown of sialic acid. read more